Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop

Introduction The Australasian Teletrial Model was piloted in co‐funded sites across Australia. The purpose was to extend the reach of clinical trials using telemedicine to improve equity and access to this treatment pathway for oncology patients. Experts across Australia gathered to share the learni...

Full description

Saved in:
Bibliographic Details
Published in:Asia-Pacific journal of clinical oncology 2022-12, Vol.18 (6), p.650-659
Main Authors: Roberts, Natasha A., Cubitt, Annette, Lindsay, Dianne, Bury, Kimberley, Dixon, Jacqueline, Gebbie, Chantal, Hawkins, Cheryl‐Ann, Major, Taylor, Jenkins‐Marsh, Sue, Morris‐Smith, Bernadette, Poxton, Melanie, Richmond, Sue, Smith, Delaine, Stoneley, Adam, Thaker, Darshit A., Wilson, Elizabeth, Woollett, Anne, Underhill, Craig, Sabesan, Sabe
Format: Article
Language:English
Subjects:
Australia
clinical trial
Clinical trials
COVID-19
Oncology
telemedicine
teletrial
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3577-e412985c4ab087522e1d3211e7a8254c7004df87ad413250e0e0ca39495907843
cites cdi_FETCH-LOGICAL-c3577-e412985c4ab087522e1d3211e7a8254c7004df87ad413250e0e0ca39495907843
container_end_page 659
container_issue 6
container_start_page 650
container_title Asia-Pacific journal of clinical oncology
container_volume 18
creator Roberts, Natasha A.
Cubitt, Annette
Lindsay, Dianne
Bury, Kimberley
Dixon, Jacqueline
Gebbie, Chantal
Hawkins, Cheryl‐Ann
Major, Taylor
Jenkins‐Marsh, Sue
Morris‐Smith, Bernadette
Poxton, Melanie
Richmond, Sue
Smith, Delaine
Stoneley, Adam
Thaker, Darshit A.
Wilson, Elizabeth
Woollett, Anne
Underhill, Craig
Sabesan, Sabe
description Introduction The Australasian Teletrial Model was piloted in co‐funded sites across Australia. The purpose was to extend the reach of clinical trials using telemedicine to improve equity and access to this treatment pathway for oncology patients. Experts across Australia gathered to share the learnings of implementation so that future directions can be effective and sustainable. Methods The 1‐day workshop was attended in person and virtually. Attendees were invited to analyze and disseminate the results. Recordings from the presentations were coded independently by three researchers and synthesized. The results were sent to the authorship team for further review to build consensus on the findings in three drafts. Results Four key themes were identified: “Being on the Same Page,” “Building Foundations,” “Key Roles in Teletrials,” and “Incentives.” Although there were many successes that were accelerated by the COVID‐19 pandemic, there is work still to be done. Conclusion The Australasian Teletrial Model has been identified as acceptable and feasible. Future directions need to continue to work on streamlining regulatory processes, implementation and monitoring, and build knowledge to further build networks across Australia.
doi_str_mv 10.1111/ajco.13737
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2624193946</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2753258338</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3577-e412985c4ab087522e1d3211e7a8254c7004df87ad413250e0e0ca39495907843</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEojc2PACyxAYhpvUlHifdoNGoF1ClQTCIZeQ6Jx0PiU-wHbXzcjxbnZkySCywFz6yv_MdS3-WvWb0lKV1ptcGT5lQQj3LDpnKxUTJqXi-r6U8yI5CWFMqSl6yl9mBkLQspooeZr-X0EL0VrfhA4krIA7uiUPffSQXDz34SDwY7DpwtY4WXSANehL3TcS6iNvGZoiDh3NyaV1t3V0CPXbbl3lrnTW6JQtnsMW7DfmGxkLcEGzIbAjR69bqv9hyNJOvEEB7syJfPDYQQho-zrvyOPTkB_qfYYX9SfaiSbfw6uk8zr5fXizn15ObxdWn-exmYoRUagI542UhTa5vaaEk58BqwRkDpQsuc6MozeumULrOmeCSQtpGizIvZUlVkYvj7N3O23v8NUCIVWeDgbbVDnAIFZ_ynJWpYZrQt_-gaxz8-PeKK5nshRBFot7vKOMxBA9N1Xvbab-pGK3GVKsx1WqbaoLfPCmH2w7qPfonxgSwHXBvW9j8R1XNPs8XO-kjDKivDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2753258338</pqid></control><display><type>article</type><title>Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Roberts, Natasha A. ; Cubitt, Annette ; Lindsay, Dianne ; Bury, Kimberley ; Dixon, Jacqueline ; Gebbie, Chantal ; Hawkins, Cheryl‐Ann ; Major, Taylor ; Jenkins‐Marsh, Sue ; Morris‐Smith, Bernadette ; Poxton, Melanie ; Richmond, Sue ; Smith, Delaine ; Stoneley, Adam ; Thaker, Darshit A. ; Wilson, Elizabeth ; Woollett, Anne ; Underhill, Craig ; Sabesan, Sabe</creator><creatorcontrib>Roberts, Natasha A. ; Cubitt, Annette ; Lindsay, Dianne ; Bury, Kimberley ; Dixon, Jacqueline ; Gebbie, Chantal ; Hawkins, Cheryl‐Ann ; Major, Taylor ; Jenkins‐Marsh, Sue ; Morris‐Smith, Bernadette ; Poxton, Melanie ; Richmond, Sue ; Smith, Delaine ; Stoneley, Adam ; Thaker, Darshit A. ; Wilson, Elizabeth ; Woollett, Anne ; Underhill, Craig ; Sabesan, Sabe</creatorcontrib><description>Introduction The Australasian Teletrial Model was piloted in co‐funded sites across Australia. The purpose was to extend the reach of clinical trials using telemedicine to improve equity and access to this treatment pathway for oncology patients. Experts across Australia gathered to share the learnings of implementation so that future directions can be effective and sustainable. Methods The 1‐day workshop was attended in person and virtually. Attendees were invited to analyze and disseminate the results. Recordings from the presentations were coded independently by three researchers and synthesized. The results were sent to the authorship team for further review to build consensus on the findings in three drafts. Results Four key themes were identified: “Being on the Same Page,” “Building Foundations,” “Key Roles in Teletrials,” and “Incentives.” Although there were many successes that were accelerated by the COVID‐19 pandemic, there is work still to be done. Conclusion The Australasian Teletrial Model has been identified as acceptable and feasible. Future directions need to continue to work on streamlining regulatory processes, implementation and monitoring, and build knowledge to further build networks across Australia.</description><identifier>ISSN: 1743-7555</identifier><identifier>EISSN: 1743-7563</identifier><identifier>DOI: 10.1111/ajco.13737</identifier><identifier>PMID: 35098670</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Australia ; clinical trial ; Clinical trials ; COVID-19 ; Oncology ; telemedicine ; teletrial</subject><ispartof>Asia-Pacific journal of clinical oncology, 2022-12, Vol.18 (6), p.650-659</ispartof><rights>2022 John Wiley &amp; Sons Australia, Ltd</rights><rights>2022 John Wiley &amp; Sons Australia, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3577-e412985c4ab087522e1d3211e7a8254c7004df87ad413250e0e0ca39495907843</citedby><cites>FETCH-LOGICAL-c3577-e412985c4ab087522e1d3211e7a8254c7004df87ad413250e0e0ca39495907843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35098670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roberts, Natasha A.</creatorcontrib><creatorcontrib>Cubitt, Annette</creatorcontrib><creatorcontrib>Lindsay, Dianne</creatorcontrib><creatorcontrib>Bury, Kimberley</creatorcontrib><creatorcontrib>Dixon, Jacqueline</creatorcontrib><creatorcontrib>Gebbie, Chantal</creatorcontrib><creatorcontrib>Hawkins, Cheryl‐Ann</creatorcontrib><creatorcontrib>Major, Taylor</creatorcontrib><creatorcontrib>Jenkins‐Marsh, Sue</creatorcontrib><creatorcontrib>Morris‐Smith, Bernadette</creatorcontrib><creatorcontrib>Poxton, Melanie</creatorcontrib><creatorcontrib>Richmond, Sue</creatorcontrib><creatorcontrib>Smith, Delaine</creatorcontrib><creatorcontrib>Stoneley, Adam</creatorcontrib><creatorcontrib>Thaker, Darshit A.</creatorcontrib><creatorcontrib>Wilson, Elizabeth</creatorcontrib><creatorcontrib>Woollett, Anne</creatorcontrib><creatorcontrib>Underhill, Craig</creatorcontrib><creatorcontrib>Sabesan, Sabe</creatorcontrib><title>Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop</title><title>Asia-Pacific journal of clinical oncology</title><addtitle>Asia Pac J Clin Oncol</addtitle><description>Introduction The Australasian Teletrial Model was piloted in co‐funded sites across Australia. The purpose was to extend the reach of clinical trials using telemedicine to improve equity and access to this treatment pathway for oncology patients. Experts across Australia gathered to share the learnings of implementation so that future directions can be effective and sustainable. Methods The 1‐day workshop was attended in person and virtually. Attendees were invited to analyze and disseminate the results. Recordings from the presentations were coded independently by three researchers and synthesized. The results were sent to the authorship team for further review to build consensus on the findings in three drafts. Results Four key themes were identified: “Being on the Same Page,” “Building Foundations,” “Key Roles in Teletrials,” and “Incentives.” Although there were many successes that were accelerated by the COVID‐19 pandemic, there is work still to be done. Conclusion The Australasian Teletrial Model has been identified as acceptable and feasible. Future directions need to continue to work on streamlining regulatory processes, implementation and monitoring, and build knowledge to further build networks across Australia.</description><subject>Australia</subject><subject>clinical trial</subject><subject>Clinical trials</subject><subject>COVID-19</subject><subject>Oncology</subject><subject>telemedicine</subject><subject>teletrial</subject><issn>1743-7555</issn><issn>1743-7563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1DAUhiMEojc2PACyxAYhpvUlHifdoNGoF1ClQTCIZeQ6Jx0PiU-wHbXzcjxbnZkySCywFz6yv_MdS3-WvWb0lKV1ptcGT5lQQj3LDpnKxUTJqXi-r6U8yI5CWFMqSl6yl9mBkLQspooeZr-X0EL0VrfhA4krIA7uiUPffSQXDz34SDwY7DpwtY4WXSANehL3TcS6iNvGZoiDh3NyaV1t3V0CPXbbl3lrnTW6JQtnsMW7DfmGxkLcEGzIbAjR69bqv9hyNJOvEEB7syJfPDYQQho-zrvyOPTkB_qfYYX9SfaiSbfw6uk8zr5fXizn15ObxdWn-exmYoRUagI542UhTa5vaaEk58BqwRkDpQsuc6MozeumULrOmeCSQtpGizIvZUlVkYvj7N3O23v8NUCIVWeDgbbVDnAIFZ_ynJWpYZrQt_-gaxz8-PeKK5nshRBFot7vKOMxBA9N1Xvbab-pGK3GVKsx1WqbaoLfPCmH2w7qPfonxgSwHXBvW9j8R1XNPs8XO-kjDKivDw</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Roberts, Natasha A.</creator><creator>Cubitt, Annette</creator><creator>Lindsay, Dianne</creator><creator>Bury, Kimberley</creator><creator>Dixon, Jacqueline</creator><creator>Gebbie, Chantal</creator><creator>Hawkins, Cheryl‐Ann</creator><creator>Major, Taylor</creator><creator>Jenkins‐Marsh, Sue</creator><creator>Morris‐Smith, Bernadette</creator><creator>Poxton, Melanie</creator><creator>Richmond, Sue</creator><creator>Smith, Delaine</creator><creator>Stoneley, Adam</creator><creator>Thaker, Darshit A.</creator><creator>Wilson, Elizabeth</creator><creator>Woollett, Anne</creator><creator>Underhill, Craig</creator><creator>Sabesan, Sabe</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202212</creationdate><title>Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop</title><author>Roberts, Natasha A. ; Cubitt, Annette ; Lindsay, Dianne ; Bury, Kimberley ; Dixon, Jacqueline ; Gebbie, Chantal ; Hawkins, Cheryl‐Ann ; Major, Taylor ; Jenkins‐Marsh, Sue ; Morris‐Smith, Bernadette ; Poxton, Melanie ; Richmond, Sue ; Smith, Delaine ; Stoneley, Adam ; Thaker, Darshit A. ; Wilson, Elizabeth ; Woollett, Anne ; Underhill, Craig ; Sabesan, Sabe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3577-e412985c4ab087522e1d3211e7a8254c7004df87ad413250e0e0ca39495907843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Australia</topic><topic>clinical trial</topic><topic>Clinical trials</topic><topic>COVID-19</topic><topic>Oncology</topic><topic>telemedicine</topic><topic>teletrial</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roberts, Natasha A.</creatorcontrib><creatorcontrib>Cubitt, Annette</creatorcontrib><creatorcontrib>Lindsay, Dianne</creatorcontrib><creatorcontrib>Bury, Kimberley</creatorcontrib><creatorcontrib>Dixon, Jacqueline</creatorcontrib><creatorcontrib>Gebbie, Chantal</creatorcontrib><creatorcontrib>Hawkins, Cheryl‐Ann</creatorcontrib><creatorcontrib>Major, Taylor</creatorcontrib><creatorcontrib>Jenkins‐Marsh, Sue</creatorcontrib><creatorcontrib>Morris‐Smith, Bernadette</creatorcontrib><creatorcontrib>Poxton, Melanie</creatorcontrib><creatorcontrib>Richmond, Sue</creatorcontrib><creatorcontrib>Smith, Delaine</creatorcontrib><creatorcontrib>Stoneley, Adam</creatorcontrib><creatorcontrib>Thaker, Darshit A.</creatorcontrib><creatorcontrib>Wilson, Elizabeth</creatorcontrib><creatorcontrib>Woollett, Anne</creatorcontrib><creatorcontrib>Underhill, Craig</creatorcontrib><creatorcontrib>Sabesan, Sabe</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Asia-Pacific journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roberts, Natasha A.</au><au>Cubitt, Annette</au><au>Lindsay, Dianne</au><au>Bury, Kimberley</au><au>Dixon, Jacqueline</au><au>Gebbie, Chantal</au><au>Hawkins, Cheryl‐Ann</au><au>Major, Taylor</au><au>Jenkins‐Marsh, Sue</au><au>Morris‐Smith, Bernadette</au><au>Poxton, Melanie</au><au>Richmond, Sue</au><au>Smith, Delaine</au><au>Stoneley, Adam</au><au>Thaker, Darshit A.</au><au>Wilson, Elizabeth</au><au>Woollett, Anne</au><au>Underhill, Craig</au><au>Sabesan, Sabe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop</atitle><jtitle>Asia-Pacific journal of clinical oncology</jtitle><addtitle>Asia Pac J Clin Oncol</addtitle><date>2022-12</date><risdate>2022</risdate><volume>18</volume><issue>6</issue><spage>650</spage><epage>659</epage><pages>650-659</pages><issn>1743-7555</issn><eissn>1743-7563</eissn><abstract>Introduction The Australasian Teletrial Model was piloted in co‐funded sites across Australia. The purpose was to extend the reach of clinical trials using telemedicine to improve equity and access to this treatment pathway for oncology patients. Experts across Australia gathered to share the learnings of implementation so that future directions can be effective and sustainable. Methods The 1‐day workshop was attended in person and virtually. Attendees were invited to analyze and disseminate the results. Recordings from the presentations were coded independently by three researchers and synthesized. The results were sent to the authorship team for further review to build consensus on the findings in three drafts. Results Four key themes were identified: “Being on the Same Page,” “Building Foundations,” “Key Roles in Teletrials,” and “Incentives.” Although there were many successes that were accelerated by the COVID‐19 pandemic, there is work still to be done. Conclusion The Australasian Teletrial Model has been identified as acceptable and feasible. Future directions need to continue to work on streamlining regulatory processes, implementation and monitoring, and build knowledge to further build networks across Australia.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35098670</pmid><doi>10.1111/ajco.13737</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1743-7555
ispartof Asia-Pacific journal of clinical oncology, 2022-12, Vol.18 (6), p.650-659
issn 1743-7555
1743-7563
language eng
recordid cdi_proquest_miscellaneous_2624193946
source Wiley-Blackwell Read & Publish Collection
subjects Australia
clinical trial
Clinical trials
COVID-19
Oncology
telemedicine
teletrial
title Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A53%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Teletrials,%20the%20new%20norm?%20Expert%20recommendations%20for%20teletrials%20into%20the%20future:%20Findings%20from%20the%20Clinical%20Oncology%20Society%20of%20Australia%20Clinical%20Trial%20Research%20Professionals%20Group%20Workshop&rft.jtitle=Asia-Pacific%20journal%20of%20clinical%20oncology&rft.au=Roberts,%20Natasha%20A.&rft.date=2022-12&rft.volume=18&rft.issue=6&rft.spage=650&rft.epage=659&rft.pages=650-659&rft.issn=1743-7555&rft.eissn=1743-7563&rft_id=info:doi/10.1111/ajco.13737&rft_dat=%3Cproquest_cross%3E2753258338%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3577-e412985c4ab087522e1d3211e7a8254c7004df87ad413250e0e0ca39495907843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2753258338&rft_id=info:pmid/35098670&rfr_iscdi=true